Population
Myosin subfragment 1 (SF1)
Comparison
Thiol cross-linking agents of different spanning… vs Reversibly bound epsilon ADP and free epsilon ADP
Design
Preclinical
Authors
Loading...
Should not change cardiovascular practice; hypothesis-generating for myosin-targeted drug design.
Trapping of ADP at the myosin active site by thiol cross-linking agents likely occurs via indirect stabilization of a conformation favoring bound nucleotides rather than direct steric hindrance.
Perkins et al. (1984) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: